Breast Ductal Carcinoma — Trials

Breast Ductal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 60
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05183828	Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer	terminated	Phase 4	62	University of WashingtonOTHER	1	Jun 4, 2026	clinicaltrials
NCT04790305	Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer	recruiting	Phase 4	1,072	Fudan UniversityOTHER	1	Jun 27, 2024	clinicaltrials